Showing results (1581-1590 of 2,199) with videos related to
Sort By:
Pageof 220
Developments in Biological Standardization|January 1, 1987
Control of therapeutic goods produced by recombinant DNA technologyA BreschkinDevelopments in Biological Standardization|January 1, 1986
Studies on the minimal number of animals required to achieve assurance of satisfactory potency in diphtheria and tetanus vaccinesP A Knight, P A RobertsDevelopments in Biological Standardization|January 1, 1987
Risk of neoplastic transformation from cellular DNA: calculations using the oncogene modelJ C Petricciani, P J ReganDevelopments in Biological Standardization|January 1, 1987
Large scale chromatographic purification of alpha 1-antitrypsin from human plasma supernatant II + IIIT Burnouf, J Constans, A Clerc, et al.Developments in Biological Standardization|January 1, 1987
Blood grouping with monoclonal antibodiesC Harbour, A FletcherDevelopments in Biological Standardization|January 1, 1987
Regulatory control of blood products in CanadaD W Boucher, J FureszDevelopments in Biological Standardization|January 1, 1987
Quality criteria for i.v. immunoglobulins: importance of tests and product propertiesP Gronski, E J Kanzy, H J Ronneberger, et al.Developments in Biological Standardization|January 1, 1986
Single radial immunodiffusion assays for the standardization of the antigenic content of rabies vaccinesM Ferguson, V Seagroatt, G C SchildDevelopments in Biological Standardization|January 1, 1986
The reduction of the number of animals used in the biological assay of insulinJ Trethewey, D Baxter, B V Fisher, et al.Developments in Biological Standardization|January 1, 1986
Comparative studies of two potency tests for antirabies serum: neutralization test in mice (MNT) and rapid fluorescent focus inhibition test (RFFIT)J Kurz, I Vogel, F Gerstl, et al.Pageof 220